Analysis of uterine corpus endometrial carcinoma and esophageal carcinoma, two cancer types with the most prominent SHANK2 overexpression, showed that expression of SHANK2 positively correlates with CTGF and CYR61 (Fig. 3G). The gene discussed is CCN2; the disease is uterine corpus endometrial carcinoma.